Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Widget

Add BioCurex widget to your own site or blog

Email Updates

Search

AGORACOM News Flash

AGORACOM CONFERENCE UPDATE

  • 12 More Companies Added To Schedule For Dec 3 & 4. (See Schedule)
  • Keynote Speakers Include Peter Grandich, Eric Coffin (See Speakers)
  • Workshop Presentations Added To Thursday Schedule
  • Investors from over 45 Countries Have Visited
  • Conference Begins 2 Weeks From Today!

Looking forward to seeing all of you there gang.  Registration is free for investors.  AGORACOM Members register with just one click.  Non-members takes less than 60 seconds.  Register here (see form on right hand side)

 

Message: Concerns over dilution

Monopoly-money-bags_profile
Rank: [?]
Mail Room
Points: [?]
126
Rating: [?]
Votes: 2 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Concerns over dilution

posted on Oct 22, 09 01:29PM

The proposal is to increase the authorized share which causes no dilution to shareholders. Increasing the number of shares outstanding would cause dilution if the Company issues new shares.

I believe that Dr. Morro has been very frugal with his cash management up until now; I believe that he will continue to manage the company that way.

No investor wants dilution because it would decrease their ownership percentage and the per share value of the Company’s stock in a takeover offer.

I own more than 700,000 shares of the Company’s stock and I voted all of my shares in favor of the proposal to increase the authorized number of shares outstanding. There are many reasons that a Company increases their outstanding shares.

The Company does need more money to get from an R&D company to a company selling product and receiving revenues.

There are many exciting reasons to hold the stock and to buy more. When we buy shares in the open market it supports the market value of the stock but it doesn’t give the company any new working capital or get us any closer to bringing product to market. If the Company does a secondary offering, it brings in cash that the Company can utilize to get its product to market.

I believe that our stock will be worth more if Dr. Morro can get the cash he needs to get us across the finish line.

New Message

Please login to post a reply

AGORACOM Quick Tips

AGORACOM 100 - The Top 100 Small Caps ... Find Your Next Investment

Executive Address

Bocx-ricardo-ea
Dr. Ricardo Moro
President & CEO
November 27, 2008

Dr. Moro discusses Biocurex's latest developments

View Broadcast

Stock Quote